This trial collects and tests samples to find personalized treatments for mantle cell lymphoma patients who have relapsed or are refractory to current treatment.
1 Primary · 5 Secondary · Reporting Duration: Up to 1 year
Experimental Treatment
20 Total Participants · 1 Treatment Group
Primary Treatment: Follow-Up · No Placebo Group · N/A
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: